MX2012000768A - Derivados de tazaroteno. - Google Patents
Derivados de tazaroteno.Info
- Publication number
- MX2012000768A MX2012000768A MX2012000768A MX2012000768A MX2012000768A MX 2012000768 A MX2012000768 A MX 2012000768A MX 2012000768 A MX2012000768 A MX 2012000768A MX 2012000768 A MX2012000768 A MX 2012000768A MX 2012000768 A MX2012000768 A MX 2012000768A
- Authority
- MX
- Mexico
- Prior art keywords
- derivatives
- tazarotene
- pharmaceutical compositions
- refers
- formation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21379409P | 2009-07-16 | 2009-07-16 | |
| US27225709P | 2009-09-04 | 2009-09-04 | |
| PCT/US2010/042225 WO2011009023A1 (en) | 2009-07-16 | 2010-07-16 | Tazarotene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012000768A true MX2012000768A (es) | 2012-02-13 |
Family
ID=43449815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012000768A MX2012000768A (es) | 2009-07-16 | 2010-07-16 | Derivados de tazaroteno. |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20120115909A1 (en:Method) |
| EP (1) | EP2453746A4 (en:Method) |
| JP (1) | JP5635090B2 (en:Method) |
| KR (1) | KR101536806B1 (en:Method) |
| CN (1) | CN102595892B (en:Method) |
| AU (1) | AU2010273261B2 (en:Method) |
| BR (1) | BR112012001680A2 (en:Method) |
| CA (1) | CA2768015C (en:Method) |
| EA (1) | EA022322B1 (en:Method) |
| IL (1) | IL217519A (en:Method) |
| IN (1) | IN2012DN00546A (en:Method) |
| MX (1) | MX2012000768A (en:Method) |
| NZ (1) | NZ598240A (en:Method) |
| SG (1) | SG177579A1 (en:Method) |
| WO (1) | WO2011009023A1 (en:Method) |
| ZA (1) | ZA201200253B (en:Method) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201105050D0 (en) | 2011-03-25 | 2011-05-11 | Iiaa Ltd | Pharmaceutical agent |
| KR102164567B1 (ko) * | 2011-06-24 | 2020-10-12 | 쥐알아이 바이오,아이엔씨. | 염증 질환의 예방 및 치료 |
| CN106918676B (zh) * | 2015-12-24 | 2020-08-11 | 重庆华邦制药有限公司 | 分离测定他扎罗汀倍他米松乳膏中两种药物含量及有关物质的方法 |
| CN107176945B (zh) * | 2016-03-11 | 2021-06-08 | 中国科学院上海有机化学研究所 | 一种视黄酸类化合物、其制备方法、中间体及应用 |
| WO2017152725A1 (zh) * | 2016-03-11 | 2017-09-14 | 中国科学院上海有机化学研究所 | 一种视黄酸类化合物、其制备方法、中间体及应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801593A (en) * | 1979-09-13 | 1989-01-31 | Burroughs Wellcome Co. | Chemotherapeutic agents |
| US5399561A (en) | 1989-09-19 | 1995-03-21 | Allergan, Inc. | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
| US5272156A (en) | 1989-09-19 | 1993-12-21 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US4980369A (en) | 1989-09-19 | 1990-12-25 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
| US5183827A (en) * | 1989-09-19 | 1993-02-02 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5045551A (en) | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| US5162546A (en) | 1989-09-19 | 1992-11-10 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| FI931625A7 (fi) | 1990-10-09 | 1993-06-07 | Allergan Inc | Retinoidikaltaisen aktiivisuuden omaavat kromaanit ja tiokromaanit |
| ATE144258T1 (de) | 1991-02-13 | 1996-11-15 | Allergan Inc | 7-phenylethynyl-substituierte chromane und thiochromane mit retinoid-ähnlicher biologischer aktivität |
| JP3157523B2 (ja) | 1991-03-26 | 2001-04-16 | アラーガン、インコーポレイテッド | レチノイド様生物学的活性を有する７位にヘテロアリールエチニル置換基を有するクロマンおよびチオクロマン |
| CN1133422C (zh) * | 1997-07-08 | 2004-01-07 | 科斯莫弗姆有限公司 | 过氧化苯甲酰和第二种活性成分的组合的局部用药 |
| DK1100490T3 (da) * | 1998-07-28 | 2007-04-10 | Susan Bershad | Behandling med kort kontakttid af acne og fotoældning med topiske retinoider |
| US6048902A (en) * | 1999-02-12 | 2000-04-11 | Lebwohl; Mark G. | Short contact treatment of psoriasis with topical retinoids |
| FR2830449B1 (fr) * | 2001-10-05 | 2004-04-23 | Fabre Pierre Dermo Cosmetique | Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant |
| CN1210041C (zh) * | 2003-09-29 | 2005-07-13 | 中国医学科学院皮肤病研究所 | 治疗痤疮的复方外用药物 |
| ITMI20050357A1 (it) * | 2005-03-08 | 2006-09-09 | Solmag S P A | Procedimento di preparazione del tazarotene |
| AR054805A1 (es) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | Composiciones topicas para el tratamiento de la piel |
| US9107844B2 (en) * | 2006-02-03 | 2015-08-18 | Stiefel Laboratories Inc. | Topical skin treating compositions |
| MXPA06008988A (es) * | 2006-08-08 | 2008-02-07 | Fernando Ahumada Ayala | Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas). |
| ES2912051T3 (es) * | 2007-02-01 | 2022-05-24 | Sol Gel Tech Ltd | Composiciones para aplicación tópica que comprenden un peróxido y retinoide |
-
2010
- 2010-07-16 CN CN201080041425.7A patent/CN102595892B/zh not_active Expired - Fee Related
- 2010-07-16 US US13/383,869 patent/US20120115909A1/en not_active Abandoned
- 2010-07-16 AU AU2010273261A patent/AU2010273261B2/en not_active Ceased
- 2010-07-16 CA CA2768015A patent/CA2768015C/en not_active Expired - Fee Related
- 2010-07-16 SG SG2012001509A patent/SG177579A1/en unknown
- 2010-07-16 JP JP2012520808A patent/JP5635090B2/ja not_active Expired - Fee Related
- 2010-07-16 MX MX2012000768A patent/MX2012000768A/es active IP Right Grant
- 2010-07-16 NZ NZ598240A patent/NZ598240A/xx not_active IP Right Cessation
- 2010-07-16 IN IN546DEN2012 patent/IN2012DN00546A/en unknown
- 2010-07-16 WO PCT/US2010/042225 patent/WO2011009023A1/en not_active Ceased
- 2010-07-16 EP EP10800590.1A patent/EP2453746A4/en not_active Withdrawn
- 2010-07-16 BR BRBR112012001680-6A patent/BR112012001680A2/pt not_active IP Right Cessation
- 2010-07-16 KR KR1020127003938A patent/KR101536806B1/ko not_active Expired - Fee Related
- 2010-07-16 EA EA201270176A patent/EA022322B1/ru not_active IP Right Cessation
-
2012
- 2012-01-12 IL IL217519A patent/IL217519A/en not_active IP Right Cessation
- 2012-01-12 ZA ZA2012/00253A patent/ZA201200253B/en unknown
-
2014
- 2014-08-20 US US14/464,060 patent/US20140357669A1/en not_active Abandoned
- 2014-08-20 US US14/463,985 patent/US9062037B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010273261B2 (en) | 2013-07-25 |
| EP2453746A1 (en) | 2012-05-23 |
| EA022322B1 (ru) | 2015-12-30 |
| US20140357669A1 (en) | 2014-12-04 |
| EP2453746A4 (en) | 2013-04-24 |
| AU2010273261A1 (en) | 2012-02-02 |
| CN102595892B (zh) | 2014-09-10 |
| ZA201200253B (en) | 2013-05-29 |
| WO2011009023A1 (en) | 2011-01-20 |
| US20140357672A1 (en) | 2014-12-04 |
| IL217519A (en) | 2015-06-30 |
| IL217519A0 (en) | 2012-02-29 |
| US9062037B2 (en) | 2015-06-23 |
| JP5635090B2 (ja) | 2014-12-03 |
| IN2012DN00546A (en:Method) | 2015-06-12 |
| JP2012533564A (ja) | 2012-12-27 |
| BR112012001680A2 (pt) | 2015-09-01 |
| KR101536806B1 (ko) | 2015-07-14 |
| CN102595892A (zh) | 2012-07-18 |
| NZ598240A (en) | 2013-10-25 |
| SG177579A1 (en) | 2012-02-28 |
| EA201270176A1 (ru) | 2012-08-30 |
| CA2768015C (en) | 2016-03-15 |
| US20120115909A1 (en) | 2012-05-10 |
| CA2768015A1 (en) | 2011-01-20 |
| KR20120056821A (ko) | 2012-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
| CO6571913A2 (es) | Derivados de fumarato de ácido graso y sus usos | |
| ECSP12012125A (es) | Ariltriazolonas ligadas a bisarilo y su uso | |
| CO7111303A2 (es) | Compuestos de microarn y métodos de modulación de la actividad de mir-21 | |
| DOP2017000013A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| MX386820B (es) | Microcápsulas lipídicas que comprenden de preferencia un retinoide y composición que las contiene, su procedimiento de preparación y su uso en dermatología. | |
| GT201400147A (es) | Pirimidinas y triazinas fusionadas sustituidas y su uso | |
| CL2012000590A1 (es) | Proceso para preparar w-transaminasa (r)-selectiva. | |
| CL2013002612A1 (es) | Compuestos derivados de c4-monometil triterpenoides; composicion farmaceutica que los comprende; y metodo para tratar o prevenir una enfermedad o un trastorno. | |
| BR112016009889A2 (pt) | ?compostos agonistas duplos gip-glp-1 e métodos? | |
| UY34123A (es) | Método para la oxidación catalítica de la celulosa y método para hacer un producto de celulosa. | |
| BR112013028534A2 (pt) | compostos tricíclicos parcialmente saturados e métodos para produção e utilização dos mesmos | |
| GT201400063A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| UY32809A (es) | Compuestos y composiciones como inhibidores de cinasa s y k | |
| UY33917A (es) | ?composiciones para recubrimiento que comprenden submicropartículas que comprenden carbonato de calcio, proceso para prepararlas, y uso de las submicropartículas?. | |
| JO3091B1 (ar) | مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها | |
| MX2019003090A (es) | Compuestos de microarn y metodos para modular la actividad de mir-21. | |
| ECSP14013153A (es) | Compuestos inhibidores de metaloenzimas | |
| GT201400131A (es) | Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina | |
| CR20140553A (es) | Compuestos de fenoxietil piperidina | |
| BR112013031795A2 (pt) | método para tratar uma doença | |
| BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
| CL2014000289A1 (es) | Compuestos derivados de 3,4-dihidro-1h-[1,8]naftiridonas sustituidas, inhibidores de la actividad de la enzima fabl; proceso para preparar dichos compuestos; composicion farmaceutica que los comprende; y proceso para preparar esta composicion farmaceutica. | |
| PA8846201A1 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
| CL2015000434A1 (es) | Metodo para el tratamiento, prevencion o disminucion de la severidad de una condicion o trastorno no neoplasico de la piel que comprende administrar un compuesto derivado de retinoides; composicion dermica que comprende los derivados de retinoide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |